Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Atto, Billio"'
Autor:
Chiara Ronchini, Federica Gigli, Martina Fontanini, Raffaella Furgi, Viviana Amato, Fabio Giglio, Giuliana Gregato, Francesco Bertolini, Michela Rondoni, Francesco Lanza, Atto Billio, Enrico Derenzini, Corrado Tarella, Pier Giuseppe Pelicci, Myriam Alcalay, Elisabetta Todisco
Publikováno v:
Cancer Reports, Vol 7, Iss 8, Pp n/a-n/a (2024)
ABSTRACT Background Myeloid neoplasms, including acute myeloid leukemia, have been traditionally among the less investigated cancer types concerning germline predisposition. Indeed, myeloid neoplasms with germline predisposition are challenging to id
Externí odkaz:
https://doaj.org/article/312eb4c785b947f59cd6b468f1e9c1b6
Autor:
Raffaele Palmieri, Atto Billio, Felicetto Ferrara, Sara Galimberti, Roberto M. Lemoli, Elisabetta Todisco, Federico Moretti, Adriano Venditti
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
In patients with Acute Myeloid Leukemia (AML), the assessment of disease risk plays a central role in the era of personalized medicine. Indeed, integrating baseline clinical and biological features on a case-by-case basis is not only essential to sel
Externí odkaz:
https://doaj.org/article/04809ebf7d18461cb71b1d71159b3eda
Autor:
Antonio Cuneo, Anthony R. Mato, Gian Matteo Rigolin, Alfonso Piciocchi, Massimo Gentile, Luca Laurenti, John N. Allan, John M. Pagel, Danielle M. Brander, Brian T. Hill, Allison Winter, Nicole Lamanna, Constantine S. Tam, Ryan Jacobs, Frederick Lansigan, Paul M. Barr, Mazyar Shadman, Alan P. Skarbnik, Jeffrey J. Pu, Alison R. Sehgal, Stephen J. Schuster, Nirav N. Shah, Chaitra S. Ujjani, Lindsey Roeker, Ester Maria Orlandi, Atto Billio, Livio Trentin, Martin Spacek, Monia Marchetti, Alessandra Tedeschi, Fiorella Ilariucci, Gianluca Gaidano, Michael Doubek, Lucia Farina, Stefano Molica, Francesco Di Raimondo, Marta Coscia, Francesca Romana Mauro, Javier de la Serna, Angeles Medina Perez, Isacco Ferrarini, Giuseppe Cimino, Maurizio Cavallari, Rosalba Cucci, Marco Vignetti, Robin Foà, Paolo Ghia, the GIMEMA, European Research Initiative (ERIC) on CLL, US study group
Publikováno v:
Cancer Medicine, Vol 9, Iss 22, Pp 8468-8479 (2020)
Abstract Limited information is available on the efficacy of front‐line bendamustine and rituximab (BR) in chronic lymphocytic leukemia (CLL) with reduced renal function or coexisting conditions. We therefore analyzed a cohort of real‐world patie
Externí odkaz:
https://doaj.org/article/51d4f3af2edb4e18930e0b7ba14d8eff
Autor:
Riccardo Bruna, Fabio Benedetti, Carola Boccomini, Caterina Patti, Anna Maria Barbui, Alessandro Pulsoni, Maurizio Musso, Anna Marina Liberati, Guido Gini, Claudia Castellino, Fausto Rossini, Fabio Ciceri, Delia Rota-Scalabrini, Caterina Stelitano, Francesco Di Raimondo, Alessandra Tucci, Liliana Devizzi, Valerio Zoli, Francesco Zallio, Franco Narni, Alessandra Dondi, Guido Parvis, Gianpietro Semenzato, Francesco Lanza, Tommasina Perrone, Francesco Angrilli, Atto Billio, Angela Gueli, Barbara Mantoan, Alessandro Rambaldi, Alessandro Massimo Gianni, Paolo Corradini, Roberto Passera, Marco Ladetto, Corrado Tarella
Publikováno v:
Haematologica, Vol 104, Iss 11 (2019)
A prospective trial conducted in the period 2000-2005 showed no survival advantage for high-dose chemotherapy with rituximab and autograft (R-HDS) versus conventional chemotherapy with rituximab (CHOP-R) as first-line therapy in 134 high-risk follicu
Externí odkaz:
https://doaj.org/article/c193a18093614c09a942ad6712274271
Autor:
Antonio Cuneo, George Follows, Gian Matteo Rigolin, Alfonso Piciocchi, Alessandra Tedeschi, Livio Trentin, Angeles Medina Perez, Marta Coscia, Luca Laurenti, Gerardo Musuraca, Lucia Farina, Alfredo Rivas Delgado, Ester Maria Orlandi, Piero Galieni, Francesca Romana Mauro, Carlo Visco, Angela Amendola, Atto Billio, Roberto Marasca, Annalisa Chiarenza, Vittorio Meneghini, Fiorella Ilariucci, Monia Marchetti, Stefano Molica, Francesca Re, Gianluca Gaidano, Marcos Gonzalez, Francesco Forconi, Stefania Ciolli, Agostino Cortelezzi, Marco Montillo, Lukas Smolej, Anna Schuh, Toby A. Eyre, Ben Kennedy, Kris M. Bowles, Marco Vignetti, Javier de la Serna, Carol Moreno, Robin Foà, Paolo Ghia
Publikováno v:
Haematologica, Vol 103, Iss 7 (2018)
We performed an observational study on the efficacy of ben-damustine and rituximab (BR) as first salvage regimen in chronic lymphocytic leukemia (CLL). In an intention-to-treat analysis including 237 patients, the median progression-free survival (PF
Externí odkaz:
https://doaj.org/article/7436cf553c6e4c1e85fc69a7ecf937a8
Autor:
Mariella D'Adda, Anna Falanga, Monica Carpenedo, Luca Barcella, Atto Billio, Marina Marchetti, Patricia Gomez-Rosas, Maurizio Cefis, Laura Russo, Vincenzo Toschi, Gloria Caldara, Massimiliano Bruno Franco, Savignano C, Alessandro Rambaldi, Francesca Schieppati
Publikováno v:
American Journal of Hematology. 95:953-959
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a life-threatening immune-mediated thrombotic microangiopathy. Daily therapeutic plasma exchange (TPE) and the optimized use of rituximab have strikingly improved the outcome of this disea
Autor:
Michele Merli, Isacco Ferrarini, Francesco Merli, Alessandro Busca, Roberto Mina, Brunangelo Falini, Riccardo Bruna, Roberto Cairoli, Monia Marchetti, Alessandra Romano, Michele Cavo, Luca Arcaini, Livio Trentin, Chiara Cattaneo, Enrico Derenzini, Nicola Stefano Fracchiolla, Francesco Marchesi, Annamaria Scattolin, Atto Billio, Monica Bocchia, Massimo Massaia, Carlo Gambacorti‐Passerini, Francesca Romana Mauro, Massimo Gentile, Sara Mohamed, Matteo Giovanni Della Porta, Elisa Coviello, Daniela Cilloni, Giuseppe Visani, Augusto Bramante Federici, Maria Chiara Tisi, Laura Cudillo, Sara Galimberti, Filippo Gherlinzoni, Livio Pagano, Anna Guidetti, Lorenza Bertù, Paolo Corradini, Francesco Passamonti, Carlo Visco
COVID-19, the disease caused by SARS-CoV-2, is still afflicting thousands of people across the globe. Few studies on COVID-19 in chronic lymphocytic leukemia (CLL) are available. Here, we analyzed data from the CLL cohort of the Italian Hematology Al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e896a46defa346fed22a387f3cd575e
https://hdl.handle.net/20.500.11769/542050
https://hdl.handle.net/20.500.11769/542050
Autor:
Maria Cristina Miggiano, Marzia Salvucci, Massimiliano Bonifacio, Elisabetta Calistri, Monica Poggiaspalla, Gianni Binotto, Atto Billio, Claudia Minotto, Alessandro Lucchesi, Elena Trabacchi, Francesco Cavazzini, Anna Merli, Mauro Krampera, Sara Galimberti, Antonella Gozzini, Isabella Capodanno, Gabriele Gugliotta, Barbara Scappini, Mario Tiribelli, Gianantonio Rosti, Monica Crugnola, Fausto Castagnetti
Publikováno v:
Targeted Oncology
In chronic-phase chronic myeloid leukemia (CML), tyrosine kinase inhibitors (TKIs) are the standard of care, and treatment-free remission (TFR) following the achievement of a stable deep molecular response (DMR) has become, alongside survival, a prim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4701d20f76e355ef31c666ae5c730ed7
https://hdl.handle.net/11392/2469137
https://hdl.handle.net/11392/2469137
Autor:
Francesca, Schieppati, Laura, Russo, Marina, Marchetti, Luca, Barcella, Maurizio, Cefis, Patricia, Gomez-Rosas, Gloria, Caldara, Monica, Carpenedo, Mariella, D'Adda, Alessandro, Rambaldi, Chiara, Savignano, Atto, Billio, Massimiliano, Bruno Franco, Vincenzo, Toschi, Anna, Falanga
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a life-threatening immune-mediated thrombotic microangiopathy. Daily therapeutic plasma exchange (TPE) and the optimized use of rituximab have strikingly improved the outcome of this disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e8bdbb5a727c186f1a2674290d8551ff
http://hdl.handle.net/10281/279838
http://hdl.handle.net/10281/279838
Autor:
Francesca Patriarca, Luigi Marcheselli, Atto Billio, Paola Cristina Cappelletto, Patrizia Mondello, Alessandra Marabese, Anna Pascarella, Stefano Luminari, Sergio Cortelazzo, Stefania Badiali, Norbert Pescosta, Michael Mian, Renato Zambello, Giuseppe Tagariello
Publikováno v:
British Journal of Haematology. 185:944-947